FTSE 100
8.718,75
PKT
-40,24
PKT
-0,46
%
Werbung
Analysen zu FTSE 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.02.17 | Reckitt Benckiser Outperform | Macquarie Research | |
08.02.17 | BP buy | UBS AG | |
08.02.17 | BP Sector Perform | Robert W. Baird & Co. Incorporated | |
08.02.17 | BP buy | HSBC | |
08.02.17 | BP Outperform | BNP PARIBAS | |
08.02.17 | BP Neutral | Goldman Sachs Group Inc. | |
07.02.17 | International Consolidated Airlines Hold | Société Générale Group S.A. (SG) | |
07.02.17 | AstraZeneca Hold | HSBC | |
07.02.17 | GSK Neutral | JP Morgan Chase & Co. | |
07.02.17 | Glencore Underweight | JP Morgan Chase & Co. | |
07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
07.02.17 | Rio Tinto overweight | JP Morgan Chase & Co. | |
07.02.17 | BP buy | UBS AG | |
07.02.17 | Rio Tinto buy | UBS AG | |
07.02.17 | Rio Tinto buy | Deutsche Bank AG | |
07.02.17 | HSBC Hold | Deutsche Bank AG | |
07.02.17 | Lloyds Banking Group Hold | Deutsche Bank AG | |
06.02.17 | Rio Tinto buy | UBS AG | |
06.02.17 | Lloyds Banking Group Hold | Deutsche Bank AG | |
06.02.17 | Barclays buy | Deutsche Bank AG | |
06.02.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
06.02.17 | GSK Equal-Weight | Morgan Stanley | |
06.02.17 | Prudential overweight | Barclays Capital | |
06.02.17 | Glencore Neutral | Macquarie Research | |
06.02.17 | Rio Tinto Outperform | Macquarie Research | |
06.02.17 | AstraZeneca buy | Deutsche Bank AG | |
06.02.17 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
06.02.17 | Barclays buy | HSBC | |
06.02.17 | Lloyds Banking Group buy | HSBC | |
03.02.17 | International Consolidated Airlines Neutral | Oddo Seydler Bank AG | |
03.02.17 | Vodafone Group buy | Deutsche Bank AG | |
03.02.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
03.02.17 | HSBC Neutral | UBS AG | |
03.02.17 | Vodafone Group buy | UBS AG | |
03.02.17 | Glencore Underweight | JP Morgan Chase & Co. | |
03.02.17 | Vodafone Group overweight | JP Morgan Chase & Co. | |
03.02.17 | Reckitt Benckiser Neutral | JP Morgan Chase & Co. | |
03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
03.02.17 | Shell (ex Royal Dutch Shell) buy | S&P Capital IQ | |
03.02.17 | Vodafone Group overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.